A carregar...
Prolonged use of pegylated liposomal doxorubicin in gynecologic malignancies
Pegylated liposomal doxorubicin (PLD) is a palliative treatment option for patients with recurrent gynecologic malignancies. It has an appealing toxicity profile and responses can be prolonged. There is no consensus as to the level of cardiac toxicity. Current label warnings, National Comprehensive...
Na minha lista:
| Publicado no: | Gynecol Oncol Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6710555/ https://ncbi.nlm.nih.gov/pubmed/31467958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2019.07.012 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|